UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048661
Receipt number R000055450
Scientific Title Clinical trial for the comparison between low and high concentrated Injection Solution Ability for Colorectal endoscopic submucosal dissection: ISAC study
Date of disclosure of the study information 2022/08/13
Last modified on 2023/12/31 15:10:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial for the comparison between low and high concentrated Injection Solution Ability for Colorectal endoscopic submucosal dissection: ISAC study

Acronym

ISAC study

Scientific Title

Clinical trial for the comparison between low and high concentrated Injection Solution Ability for Colorectal endoscopic submucosal dissection: ISAC study

Scientific Title:Acronym

ISAC study

Region

Japan


Condition

Condition

colorectal tumors

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the difference of procedure time between high-concentrated and low-cencetrated injection solution n colorectal ESD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The difference of ESD procedure time between high-concentrated and low-cencetrated injection solution

Key secondary outcomes

The comparison of various therapeutic results between two groups


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

high-concentrated injection solution

Interventions/Control_2

low-concentrated injection solution

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A patient scheduled ESD for colorectal malignant tumors

Key exclusion criteria

1) FAP
2) IBD
3) severe disease of other organs

Target sample size

164


Research contact person

Name of lead principal investigator

1st name Naohisa
Middle name
Last name Yoshida

Organization

Kyoto Prefectural Univedrsity of Medicine

Division name

Molecular Gastroenterology and Hepatology

Zip code

602-8566

Address

Kajii-cho 465 Kamigyo-ku, Kyoto, Japan

TEL

075-251-5519

Email

naohisa@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Naohisa
Middle name
Last name Yoshida

Organization

Kyoto Prefectural Univedrsity of Medicine

Division name

Molecular Gastroenterology and Hepatology

Zip code

602-8566

Address

Kajii-cho 465 Kamigyo-ku, Kyoto, Japan

TEL

075-251-5519

Homepage URL


Email

naohisa@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural Univedrsity of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kyoto Prefectural Univedrsity of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Kyoto prefectural univeristy of medicine

Address

Kajii-cho 465, Kamigyo-ku, Kyoto, Japan

Tel

075-251-5337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

1. 長崎大学 (長崎県)
2. 西陣病院 (京都府)
3. 京都第一赤十字病院 (京都府)
4. 愛生会山科病院 (京都府)
5. 綾部市立病院 (京都府)
6.済生会京都病院 (京都府)
7. 京都府立医科大学(京都府)


Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 04 Month 01 Day

Date of IRB

2022 Year 04 Month 11 Day

Anticipated trial start date

2022 Year 08 Month 01 Day

Last follow-up date

2023 Year 10 Month 15 Day

Date of closure to data entry

2023 Year 10 Month 31 Day

Date trial data considered complete

2023 Year 11 Month 30 Day

Date analysis concluded

2023 Year 12 Month 04 Day


Other

Other related information



Management information

Registered date

2022 Year 08 Month 13 Day

Last modified on

2023 Year 12 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055450


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name